Aehr Test Systems (AEHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,084 | -3,910 | -1,011 | -368 | 660 |
| Depreciation Amortization | 922 | 3,388 | 2,368 | 1,459 | 566 |
| Income taxes - deferred | -761 | -421 | -293 | -90 | 144 |
| Accounts receivable | 1,140 | -3,037 | -962 | 3,718 | 2,555 |
| Accounts payable and accrued liabilities | -2,401 | -714 | 139 | -1,880 | -628 |
| Other Working Capital | -30 | -12,203 | -9,903 | -6,439 | 140 |
| Other Operating Activity | 2,932 | 9,497 | 4,564 | 107 | -1,057 |
| Operating Cash Flow | $-282 | $-7,400 | $-5,098 | $-3,493 | $2,380 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,391 | -4,992 | -2,174 | -518 | -197 |
| Net Acquisitions | N/A | -11,075 | -11,075 | -10,615 | -10,615 |
| Investing Cash Flow | $-1,391 | $-16,067 | $-13,249 | $-11,133 | $-10,812 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 170 | 1,409 | 374 | 831 | 56 |
| Common Stock Repurchased | -328 | -784 | N/A | -343 | -162 |
| Financing Cash Flow | $-158 | $625 | $374 | $488 | $-106 |
| Exchange Rate Effect | 9 | 13 | 25 | -3 | 9 |
| Beginning Cash Position | 26,480 | 49,309 | 49,309 | 49,309 | 49,309 |
| End Cash Position | 24,658 | 26,480 | 31,361 | 35,168 | 40,780 |
| Net Cash Flow | $-1,822 | $-22,829 | $-17,948 | $-14,141 | $-8,529 |
| Free Cash Flow | |||||
| Operating Cash Flow | -282 | -7,400 | -5,098 | -3,493 | 2,380 |
| Capital Expenditure | -1,391 | -4,992 | -2,174 | -518 | -197 |
| Free Cash Flow | -1,673 | -12,392 | -7,272 | -4,011 | 2,183 |